Belgium: Difference between revisions
| Line 50: | Line 50: | ||
=== [[hasClinicalGuidelines::KCE_Guidelines_(Belgium)|KCE Guidelines]] === | === [[hasClinicalGuidelines::KCE_Guidelines_(Belgium)|KCE Guidelines]] === | ||
</div> | </div> | ||
Revision as of 16:52, 30 April 2024
Go back to Cancer Centers list.
Cancer Centers
Healthcare System
Belgium's healthcare system is a compulsory, social health insurance system. It operates under a model that combines both public and private sectors, with a blend of universal coverage and income-based premiums.
The system is managed by the Ministry of Health at the national level, composed of the Federal Public Service for Health, Food Chain Safety, and Environment, and by regional governments in Flanders, Wallonia, and Brussels-Capital. Health insurance funds, known as "mutualities," are responsible for the management of the social health insurance system.
The Belgian population receives a wide range of healthcare benefits through the system, including primary care, specialist care, hospital care, mental health services, dental care, maternity care, rehabilitation services, and prescription medications. Preventive care and health promotion services are also provided. There is no gatekeeping system in place.
All Belgian residents are required to join a health insurance fund, which is typically linked to their employment or their family's employment. Access to healthcare benefits is granted upon registration with a health insurance fund, and coverage extends to dependents as well. The system is funded by income-based contributions from employees, employers, and the government, ensuring comprehensive coverage for all citizens.
Belgium has implemented a nationwide electronic health record (EHR) system called eHealth. This platform securely centralizes patients' medical records, allowing healthcare providers to access and update relevant information. Data from insurance claims, registries, and other sources is also collected and stored in the eHealth system, which aims to improve the overall efficiency and quality of care while maintaining patient privacy.
Administrative or Claims Data
Registries
Databases for Clinical Trials, Surveys and Biobanks
Clinical Practices Guidelines
Latest Policymaking Initiatives
Report: Belgian Cancer Barometer
Sponsor, manager or home institution: Stichting Tegen Kanker.
Primary purpose: To create a comprehensive reference work on cancer care in Belgium, providing a global overview and determining priorities for fighting cancer on all fronts, with the collaboration of various organizations and experts in the field.
Type of information: Number of new cancer diagnoses; Cancer incidence; Most frequent cancers; Cancer mortality, survival and prevalence; People invited, total coverage and response rate according to population survey and region of cancer screenings; Diagnoses, treatment and palliative care general information.
Data level: National and regional level.
Access to information: Access Information [1].
Report: EU Country Cancer Profile 2023
Sponsor, manager or home institution: OECD and European Commission.
Primary purpose: To provide reliable data on cancer prevention and care, identifying trends, disparities, and inequalities among EU Member States and regions to guide interventions under Europe's Beating Cancer Plan.
Type of information: National cancer burden; Cancer incidence and mortality; Risk factors for cancer; Early detection programs (screenings); Cancer care performance, The impact of COVID-19 on cancer care.
Data level: National level.
Access to information: Access Information [2].
Reports: KCE Organisation and financing of health care
Sponsor, manager or home institution: Federaal Kenniscentrum voor de Gezondheidszorg.
Primary purpose: Provides reports about the performance of the Belgian health system.
Type of information: Reports information about the performance of the Belgian health system; Palliative care; Survival and quality of care in Belgian hospitals; Integrated care, etc.
Access to information: List of reports [3].
Compilation: ESMO Patient Guides
Sponsor, manager or home institution: European Society for Medical Oncology.
Primary purpose: To translate complex medical language into understandable information for patients.
Available guides: Side Effects of Immunotherapy and Its Management; AML; Bone Sarcomas; Colorectal Cancer; Endometrial Cancer; Follicular Lymphoma; Glioma; Head and Neck Cancers; CML; Stomach Cancer; Soft Tissue Sarcomas.
Type of information: Information on each guide varies for each cancer type. Generally, guides provide definitions, explanations of causes, diagnosis, treatment, treatment options, care after treatment, among others.
Access to information: List of guides [4].
Patient Association: Lymphoma Association Flanders
Primary purpose: To support and advocate for lymphoma patients and their families while promoting awareness and improving the overall care and well-being of those affected by the disease.
Contact information: Information [5].
Patient Association: Hodgkin & non-Hodgkin
Primary purpose: To provide support and empower Hodgkin and non-Hodgkin lymphoma cancer patients through shared experiences, information sharing, advocacy, and collaboration with various related organizations.
Contact information: Information [6].
